Showing results (491-500 of 6,760) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|December 1, 2001
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavirS Hetherington, S McGuirk, G Powell, et al.Clinical Therapeutics|December 1, 2001
Respiratory illness caused by picornavirus infection: a review of clinical outcomesA S Monto, A M Fendrick, M W SarnesClinical Therapeutics|December 1, 2001
Considerations for optimal iron use for anemia due to chronic kidney diseaseJ Q Hudson, T J ComstockClinical Therapeutics|August 17, 2002
Efficacy of budesonide in inhaled corticosteroid-naive patients and patients with mild persistent asthmaHoward EigenClinical Therapeutics|August 17, 2002
Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled studyMalte Ludwig, Manfred Stapff, Artur Ribeiro, et al.Clinical Therapeutics|December 5, 2002
A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitisConstance H Katelaris, Giorgio Ciprandi, Luc Missotten, et al.Clinical Therapeutics|December 5, 2002
A model of the direct and indirect effects of aprotinin administration on the overall costs of coronary revascularization surgery in a university teaching hospital cardiothoracic unitDavid Robinson, Edward BlissClinical Therapeutics|February 13, 2003
A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxibElizabeth A Tindall, John T Sharp, Aimee Burr, et al.Clinical Therapeutics|February 13, 2003
Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in womenDan C Henry, Robert B Bettis, Ernie Riffer, et al.Clinical Therapeutics|February 13, 2003
An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitisKarl Weiss, Anita Vanjaka, Pageof 676